Home Home Home Inbox Home Search

Event

Evaluation of the Suitability of the Respimat® Inhaler for the Treatment of Preschool Children [Board No. P1001]

Location: Board no. P1001
Session Type: Thematic Poster Session
Monday
May
21
11:15 AM
1:00 PM

Speaker(s)/Author(s)

Ashish Sharma

-
Boehringer Ingelheim Pharma GmbH & Co KG

Wolfgang Kamin

MD, PhD
EVK Hamm Evangelisches Krankenhaus

Herbert Wachtel

PhD
Boehringer Ingelheim Pharma GmbH & Co KG

Matthias M. Metzger

Master of Science, Biomedical Chemistry
Johannes Gutenberg-Universität Mainz

View Abstract

Evaluation of the Suitability of the Respimat® Inhaler for the Treatment of Preschool Children

Parent Sessions

  • B65 - ASTHMA: PATHOPHYSIOLOGY AND CLINICAL TRIALS...
    05-21-2018 9:15 AM - 4:15 PM
    • Home Home Home Inbox Home Search